BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23266825)

  • 21. A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion.
    Hauge-Evans AC; King AJ; Fairhall K; Persaud SJ; Jones PM
    Islets; 2010; 2(6):341-4. PubMed ID: 21099335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.
    Tomita T
    Islets; 2011; 3(4):166-74. PubMed ID: 21633185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conflicting Views About Interactions Between Pancreatic α-Cells and β-Cells.
    Weir GC; Bonner-Weir S
    Diabetes; 2023 Dec; 72(12):1741-1747. PubMed ID: 37983524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes.
    Omar-Hmeadi M; Lund PE; Gandasi NR; Tengholm A; Barg S
    Nat Commun; 2020 Apr; 11(1):1896. PubMed ID: 32312960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of β-Cell Identity Occurs in Type 2 Diabetes and Is Associated With Islet Amyloid Deposits.
    Spijker HS; Song H; Ellenbroek JH; Roefs MM; Engelse MA; Bos E; Koster AJ; Rabelink TJ; Hansen BC; Clark A; Carlotti F; de Koning EJ
    Diabetes; 2015 Aug; 64(8):2928-38. PubMed ID: 25918235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paracrinology of islets and the paracrinopathy of diabetes.
    Unger RH; Orci L
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16009-12. PubMed ID: 20798346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of pig islet function by in vivo pancreatic tissue remodeling: a "human-like" pig islet structure with streptozotocin treatment.
    Vériter S; Aouassar N; Beaurin G; Goebbels RM; Gianello P; Dufrane D
    Cell Transplant; 2013; 22(11):2161-73. PubMed ID: 23051152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point.
    Rodriguez-Diaz R; Molano RD; Weitz JR; Abdulreda MH; Berman DM; Leibiger B; Leibiger IB; Kenyon NS; Ricordi C; Pileggi A; Caicedo A; Berggren PO
    Cell Metab; 2018 Mar; 27(3):549-558.e4. PubMed ID: 29514065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. cAMP signalling in insulin and glucagon secretion.
    Tengholm A; Gylfe E
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():42-53. PubMed ID: 28466587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
    Iki K; Pour PM
    J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-islet glucagon signaling is critical for maintaining glucose homeostasis.
    Zhu L; Dattaroy D; Pham J; Wang L; Barella LF; Cui Y; Wilkins KJ; Roth BL; Hochgeschwender U; Matschinsky FM; Kaestner KH; Doliba NM; Wess J
    JCI Insight; 2019 Apr; 5(10):. PubMed ID: 31012868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RhoA as a Signaling Hub Controlling Glucagon Secretion From Pancreatic α-Cells.
    Ng XW; Chung YH; Asadi F; Kong C; Ustione A; Piston DW
    Diabetes; 2022 Nov; 71(11):2384-2394. PubMed ID: 35904939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?
    Walker JN; Ramracheya R; Zhang Q; Johnson PR; Braun M; Rorsman P
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():95-105. PubMed ID: 21824262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
    Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
    Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian orchestration of insulin and glucagon release.
    Petrenko V; Dibner C
    Cell Cycle; 2017 Jun; 16(12):1141-1142. PubMed ID: 28537528
    [No Abstract]   [Full Text] [Related]  

  • 37. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reestablishment of Glucose Inhibition of Glucagon Secretion in Small Pseudoislets.
    Reissaus CA; Piston DW
    Diabetes; 2017 Apr; 66(4):960-969. PubMed ID: 28130310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.
    Gilon P
    J Mol Biol; 2020 Mar; 432(5):1367-1394. PubMed ID: 31954131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells.
    Braun M; Ramracheya R; Bengtsson M; Clark A; Walker JN; Johnson PR; Rorsman P
    Diabetes; 2010 Jul; 59(7):1694-701. PubMed ID: 20413510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.